AHFS December 2024 Update

This update contains 8 new monographs and 39 revised monographs.

New monographs: Arimoclomol Citrate; Artesunate; Azithromycin (EENT); Denileukin diftitox-cxdl; Deuruxolitinib Phosphate; Lebrikizumab-lbkz; Levacetylleucine; Xanomeline Tartrate and Trospium Chloride.

Revised monographs: Adagrasib; Adalimumab; Alectinib Hydrochloride; Benralizumab; Casimersen; Danicopan; Deflazacort; Dronabinol; Dupilumab; Edaravone; Eflornithine Hydrochloride; Enfuvirtide; Estrogen-Progestin Combinations; Etrasimod Arginine; Ixazomib Citrate; Ixekizumab; Lanreotide Acetate; Leniolisib Phosphate; Lidocaine Hydrochloride (Systemic); Lomustine; Midazolam, Midazolam Hydrochloride; Mirikizumab-mrkz; Nedosiran Sodium; Ozanimod Hydrochloride; Pirtobrutinib; Pozelimab-bbfg; Repotrectinib; Resmetirom; Riluzole; Sotatercept-csrk; Tepotinib Hydrochloride; Tisotumab vedotin-tftv; Tofersen; Tovorafenib; Tralokinumab-ldrm; Vadadustat; Vasopressin; Vedolizumab; Zanubrutinib.